OHA October 2017 E-Newsletter

Inside OHA - USAID's Office of HIV/AIDS. Stay Connected. Spread the Word.
A group of African women sitting for the camera, one holding an infant.

Photo credit: PATH

October 2017

OHA Strategy Launch

OHA discussed the new office strategy at a 2-day office retreat. Photo Credit: Audrey Johnson/USAID

OHA discussed the new office strategy at a 2-day office retreat. Photo Credit: Audrey Johnson/USAID

The U.S. Agency for International Development (USAID) Office of HIV/AIDS (OHA) recently launched a new Strategic Priority Framework Strategy to help the office successfully meet the evolving challenges and opportunities to reach HIV/AIDS epidemic control. The framework provides a long-term vision to guide intermediate and annual actions and resource allocations and also highlights internal processes and approaches that will facilitate OHA’s achievement of its mission and strategic priorities. OHA has identified the following as critical strategic priorities to reach over the next 3–5 years:

  • Comprehensive Continuum of HIV Services Strengthened and Expanded
  • High Impact, Evidence-based Prevention Interventions for HIV/AIDS Orphans, Vulnerable and Key Populations Expanded
  • Sustainability of HIV/AIDS Programs Increased
  • Commodity Quality and Security Strengthened
  • HIV/AIDS Strategic Information for Decision-making Improved and Institutionalized


PEPFAR Strategy Launch

PEPFAR Strategy Cover image, showing a woman smiling with four children.

Image credit: PEPFAR.gov

A new U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) strategy was launched at the U.N. General Assembly (UNGA) held in September 2017 called, PEPFAR Strategy for Accelerating HIV/AIDS Epidemic Control (2017–2020) [PDF, 2.68MB].

The Strategy reaffirms the U.S. Government’s leadership and commitment, through PEPFAR, to support HIV/AIDS efforts in more than 50 countries, ensuring access to services by all populations, including the most vulnerable and at-risk groups. The Strategy also outlines plans to accelerate implementation in a subset of 13 high-burden countries that have the potential to achieve epidemic control by 2020, working in collaboration with host governments, the Global Fund, UNAIDS and other partners not only to control the epidemic, but also to reduce the future costs required to sustain the HIV/AIDS response. Check out more PEPFAR-related resources from UNGA.


New WHO Clinical Guidelines

WHO Clinical Guidelines document cover image, showing the text of the report.

Image credit: World Health Organization

The World Health Organization released new clinical guidelines titled, Responding to Children and Adolescents Who Have Been Sexually Abused, aimed at helping frontline health workers, primarily from low-resource settings, in providing evidence-based, quality, trauma-informed care to survivors. The guidelines cover recommendations for post-rape care and mental health, as well as approaches to minimizing distress in the process of taking medical history, conducting examinations and documenting findings.




Tech Talk: Perspectives from OHA Technical Staff on the Latest in HIV/AIDS

Partnership and Innovation for ART Optimization Efforts

By Emily Harris, Public Health Advisor in OHA's Research Division

On September 21, a breakthrough pricing agreement for the first generic, single-pill HIV treatment regimen containing tenofovir, lamivudine, dolutegravir, known as TLD, was announced at the 72nd U.N. General Assembly. At a per-patient, per-year cost of US$ 75 – relative to the US$80 to US$90 paid for other regimens – TLD’s cost-effectiveness combined with its favorable clinical profile marks an important step toward accelerating access to simpler, safer and more affordable HIV treatment.

Past transitions to optimized treatment have taken nearly a decade to scale up – a time span that many are working to shorten, given the current magnitude of those in need of life-saving antiretroviral therapy, and our joint global goals aimed at expanding treatment access.

To support a more efficient TLD transition, I am working closely with my Global Health and Office of HIV/AIDS colleagues to facilitate countries' initiation and scale-up of TLD transition planning activities. Currently, our efforts range from the clinical trials and global and country-specific transition support through the OPTIMIZE project, market shaping activities with the Center for Accelerating Innovation and Impact (CII), and supply chain and procurement support through the USAID Global Health Supply Chain Program-Procurement and Supply Management project (GHSC-PSM).

We're proud of how these efforts reflect USAID's focus on partnerships and innovation, from the application of business-minded market access approaches to the wide range of stakeholders that enabled the breakthrough pricing agreement. If you're interested in learning more, many additional resources are available at USAID's ART Optimization page.

OHA Research Blog Highlights

Office of HIV & AIDS Reseach Blog. Image of a young woman before a cheering crowd.

The OHA Research Blog provides an opportunity to showcase OHA's investments and advances in basic science research, while providing a platform to gain insights from OHA’s scientific staff. The poignant, first-person accounts from OHA staff humanize the realities of HIV/AIDS research. Check out our latest post called, Building Community through HIV Treatment, which discusses how community health agents in Tanzania are providing a new method of delivering care and treatment for people living with HIV/AIDS.

Discover other recent posts:


Stay connected! Forward this e-mail, like USAID for Global Health on Facebook and follow @USAIDGH on Twitter.

Contact OHA-Communications-Team@usaid.gov for more information.

USAID is a proud implementer of the U.S. President's Emergency Plan for AIDS Relief.

    Last updated: September 12, 2019

    Share This Page